A propensity-matched study of the association of physical function and outcomes in geriatric heart failure

被引:9
作者
Ahmed, Ali [1 ,2 ]
Aronow, Wilbert S. [3 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL 35294 USA
[2] Vet Adm Med Ctr, Birmingham, AL 35233 USA
[3] New York Med Coll, Valhalla, NY 10595 USA
关键词
heart failure; geriatric patients; NYHA class; physical function; outcomes of HF in elderly;
D O I
10.1016/j.archger.2007.03.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Most heart failure (HF) patients are older adults. However, the association of functional status and outcomes in ambulatory older adults with chronic HF has not been well studied. Of the 7788 Digitalis Investigation Group (DIG) trial participants, 4036 were >= 65 years. Of these, 1369 (34%) had New York Heart Association (NYHA) class III-IV symptoms. We calculated propensity scores for NYHA III-IV symptoms for all 4036 patients using a non-parsimonious logistic regression model. We used propensity scores to match 1010 (74% of 1369) NYHA 111-IV patients with 1010 of NYHA 1-11 patients. KaplanMeier and matched Cox proportion hazard analyses were used to estimate associations of NYHA class III-IV with mortality and hospitalizations. Patients had a mean age of 73 years, 31% were female, and 11% were nonwhites. All-cause mortality occurred in 394 (rate, 1385/10000 person-years) NYHA I-II and 452 (rate, 1654/10000 person-years) NYHA III-IV patients, respectively, during 2967 and 2733 years Of follow LIP (hazard ratio: [HR], 1.28; 95% confidence interval [CI], 1.09-1.50; p = 0.002). NYHA III-IV class was associated with increased cardiovascular (HR, 1.25; 95% CI, 1.04-1.49; p = 0.016) and HF morality (HR, 1.51; 95% CI, 1.16-1.97; p = 0.002). NYHA III-IV class was not significantly associated with hospitalizations due to all causes (HR, 1.10; 95% CI, 0.96-1.25; p=0.165), cardiovascular causes (HR, 1.11; 95% CI, 0.96-1.29; p = 0.150), or worsening HF (HR, 1.09,95% CI, 0.92-1.30; p = 0.330). Baseline NYHA functional class was associated with mortality but not with hospitalization in ambulatory Older adults with chronic HE (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:161 / 172
页数:12
相关论文
共 24 条
[1]  
Abernathy GT, 1996, CONTROL CLIN TRIALS, V17, P77
[2]   Digoxin and reduction in mortality and hospitalization in heart failure:: a comprehensive post hoc analysis of the DIG trial [J].
Ahmed, A ;
Rich, MW ;
Love, TE ;
Lloyd-Jones, DM ;
Aban, IB ;
Colucci, WS ;
Adams, KF ;
Gheorghiade, M .
EUROPEAN HEART JOURNAL, 2006, 27 (02) :178-186
[3]   Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function [J].
Ahmed, A ;
Aronow, WS ;
Fleg, JL .
AMERICAN HEART JOURNAL, 2006, 151 (02) :444-450
[4]   Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods [J].
Ahmed, Ali ;
Husain, Ahsan ;
Love, Thomas E. ;
Gambassi, Giovanni ;
Dell'Italia, Louis J. ;
Francis, Gary S. ;
Gheorghiade, Mihai ;
Allman, Richard M. ;
Meleth, Sreelatha ;
Bourge, Robert C. .
EUROPEAN HEART JOURNAL, 2006, 27 (12) :1431-1439
[6]   Outcomes in ambulatory chronic systolic and diastolic heart failure: A propensity score analysis [J].
Ahmed, Ali ;
Perry, Gilbert J. ;
Fleg, Jerome L. ;
Love, Thomas E. ;
Goff, David C., Jr. ;
Kitzman, Dalane W. .
AMERICAN HEART JOURNAL, 2006, 152 (05) :956-966
[7]   A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study [J].
Austin, Peter C. ;
Grootendorst, Paul ;
Anderson, Geoffrey M. .
STATISTICS IN MEDICINE, 2007, 26 (04) :734-753
[8]   Predicting mortality in patients with heart failure: a pragmatic approach [J].
Bouvy, ML ;
Heerdink, ER ;
Leufkens, HGM ;
Hoes, AW .
HEART, 2003, 89 (06) :605-609
[9]  
CAMPANA C, 1993, J HEART LUNG TRANSPL, V12, P756
[10]   Determination of vital status at the end of the DIG trial [J].
Collins, JF ;
Howell, CL ;
Horney, A .
CONTROLLED CLINICAL TRIALS, 2003, 24 (06) :726-730